Emergence of an Unusual Sulfadoxine-Pyrimethamine Resistance Pattern and a Novel K540N Mutation in Dihydropteroate Synthetase in Plasmodium falciparum Isolates Obtained from Car Nicobar Island, India, after the 2004 Tsunami

Journal of Infectious Diseases

Volumn 199, Issue 7, 2009, Pages 1064-1073

  Lumb, Vanshika ^a   Das, Manoj K ^c   Mittra, Pooja ^a   Ahmed, Anwar ^a   Kumar, Manoj ^b   Kaur, Punit ^b   Dash, Aditya P ^b   Singh, Shiv S ^d   Sharma, Yagya D ^a,b  

^a Department of Biotechnology ^*

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

^d G B PANT HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; CHLOROQUINE; COTRIMOXAZOLE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR; PRIMAQUINE; QUININE SULFATE; ANTIMALARIAL AGENT; CARRIER PROTEIN; PFCRT PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL PROTEIN; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BINDING AFFINITY; CHLOROQUINE RESISTANCE TRANSPORTER GENE; CONTROLLED STUDY; DRUG BINDING; DRUG USE; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MUTATOR GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TSUNAMI; ALLELE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DISASTER; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; ENZYME ACTIVE SITE; ENZYMOLOGY; GENETICS; GEOGRAPHY; MUTATION; PROTEIN CONFORMATION; TIME;

ALLELES; ANIMALS; ANTIMALARIALS; CATALYTIC DOMAIN; DIHYDROPTEROATE SYNTHASE; DISASTERS; DRUG COMBINATIONS; DRUG RESISTANCE; GEOGRAPHY; INDIA; MEMBRANE TRANSPORT PROTEINS; MODELS, MOLECULAR; MUTATION; PLASMODIUM FALCIPARUM; PROTEIN CONFORMATION; PROTOZOAN PROTEINS; PYRIMETHAMINE; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE; TIDAL WAVES; TIME FACTORS;

EID: 65549160862     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597206     Document Type: Article

References (24)

1. Dzekunov SM, Ursos LM, Roepe PD. Digestive vacuolar pH of intact intraerythrocytic P. falciparum either sensitive or resistant to chloroquine. Mol Biochem Parasitol 2000; 110:107-24.
2. Krogstad DJ, Gluzman IY, Kyle DE, et al. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 1987; 238:1283-5.
3. Sanchez CP, McLean JE, Rohrbach P, Fidock DA, Stein WD, Lanzer M. Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum. Biochemistry 2005; 44:9862-70.
4. Fidock DA, Nomura T, Talley AK, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 2000; 6:861-71.
5. Sibley CH, Hyde JE, Sims PF, et al. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol 2001; 17: 582-8.
6. Djimde A, Doumbo OK, Cortese JF, et al. A molecular marker for chloroquine-resistant falciparum malaria.NEngl J Med 2001; 344:257-63.
7. Dzekunov SM, Ursos LM, Roepe PD. Digestive vacuolar pH of intact intraerythrocytic P. falciparum either sensitive or resistant to chloroquine. Mol Biochem Parasitol 2000; 110:107-24.
8. Mittra P, Vinayak S, Chandawat H, et al. Progressive increase in point mutations associated with chloroquine resistance in Plasmodium falciparum isolates from India. J Infect Dis 2006; 193:1304-12.
9. Ahmed A, Bararia D, Vinayak S, et al. Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance. Antimicrob Agents Chemother 2004; 48:879-89.
10. Ahmed A, Lumb V, Das MK, Dev V, Wajihullah, Sharma YD. Prevalence of mutations associated with higher levels of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Car Nicobar Island and Assam, India. Antimicrob Agents Chemother 2006; 50:3934-8.
11. Babaoglu K, Qi J, Lee RE, White SW. Crystal structure of 7,8-dihydropteroate synthase from Bacillus anthracis: mechanism and novel inhibitor design. Structure 2004; 12:1705-17.
12. Baca AM, Sirawaraporn R, Turley S, Sirawaraporn W, Hol WG. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action. J Mol Biol 2000; 302:1193-212.
13. Lakowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993; 26:283-91.
14. Bohm HJ. Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs. J Comput Aided Mol Des 1998; 12:309-23.
15. Zhang Y, Meshnick SR. Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs. Antimicrob Agents Chemother 1991; 35:267-71.
16. Iyer JK, Milhous WK, Cortese JF, Kublin JG, Plowe CV. Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet 2001; 358:1066-7.
17. Triglia T, Menting JG, Wilson C, Cowman AF. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci U S A 1997; 94: 13944-9.
18. Petersen E. In vitro susceptibility of Plasmodium falciparum malaria to pyrimethamine, sulfadoxine, trimethoprim and sulfamethoxazole, singly and in combination. Trans R Soc Trop Med Hyg 1987; 81:238-41.
19. Khalil I, Ronn AM, Alifrangis M, Gabar HA, Satti GM, Bygbjerg IC. Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole. Am J Trop Med Hyg 2003; 68:586-9.
20. Clyde DF, Miller RM, Schwartz AR, Levine MM. Treatment of falciparum malaria with sulfalene and trimethoprim.AmJ Trop Med Hyg 1971; 20:804-10.
21. Martin DC, Arnold JD. Treatment of acute falciparum malaria with sulfalene and trimethoprim. JAMA 1968; 203:476-80.
22. Thera MA, Sehdev PS, Coulibaly D, et al. Impact of trimethoprim- sulfamethoxazole prophylaxis on falciparum malaria infection and disease. J Infect Dis 2005; 192:1823-9.
23. Khalil IF, Ronn AM, Alifrangis M, et al. Response of Plasmodium falciparum to cotrimoxazole therapy: relationship with plasma drug concentrations and dihydrofolate reductase and dihydropteroate synthase genotypes. Am J Trop Med Hyg 2005; 73:174-7.
24. Jelinek T, Kilian AH, Curtis J, et al. Plasmodium falciparum: selection of serine 108 of dihydrofolate reductase during treatment of uncomplicated malaria with co-trimoxazole in Ugandan children. Am J Trop Med Hyg 1999; 61:125-30.